Search research articles
Contact Us
Filters
Showing results (31-40 of 33) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 33 results.
The Lancet. Infectious Diseases
|
July 17, 2025
Extended nirmatrelvir-ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial
Edward Weinstein, Roger Paredes, Annie Gardner, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 11, 2020
Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
Jéromine Klingler, Svenja Weiss, Vincenza Itri, et al.
The Journal of Infectious Diseases
|
December 28, 2020
Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
Jéromine Klingler, Svenja Weiss, Vincenza Itri, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 33) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 33 results.
The Lancet. Infectious Diseases
|
July 17, 2025
Extended nirmatrelvir-ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial
Edward Weinstein, Roger Paredes, Annie Gardner, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 11, 2020
Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
Jéromine Klingler, Svenja Weiss, Vincenza Itri, et al.
The Journal of Infectious Diseases
|
December 28, 2020
Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
Jéromine Klingler, Svenja Weiss, Vincenza Itri, et al.
Page
of 4